CRBN and hematologic disorder: Our study underscores the significant potential of MGD-C9, serve as a highly potent CRBN ligand and a promising candidate for the treatment of hematological malignancies, which not only stands out as a highly potent CRBN ligand but also emerges as a promising candidate for the treatment of hematological malignancies.